Fabienne Gac-Nedelec
Rennes, 35000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Interference of oral anti-Xa anticoagulants during monitoring of unfractionated heparin treatments: practical and future attitudes
Journal: Annales de biologie clinique
Published: June 04, 2024
Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 30, 2024
Factors Influencing Anti-Xa Assays: A Multicenter Prospective Study in Critically Ill and Noncritically Ill Patients Receiving Unfractionated Heparin.
Journal: Thrombosis and haemostasis
Published: June 15, 2023
A performance evaluation of sthemO 301 coagulation analyzer and associated reagents.
Journal: Journal of clinical laboratory analysis
Published: October 25, 2022
Impact of age on in vitro metabolism of clopidogrel: a potential explanation for high on-treatment platelet reactivity in the elderly?
Journal: Research and practice in thrombosis and haemostasis
Published: May 25, 2022
Heparin-induced thrombocytopenia leading to a diagnosis of essential thrombocythemia.
Journal: International journal of laboratory hematology
Published: November 25, 2020
Management of a High-Risk Surgery with Emicizumab and Factor VIII in a Child with a Severe Hemophilia A and Inhibitor.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: November 15, 2020
Platelet Functions During Extracorporeal Membrane Oxygenation. Platelet-Leukocyte Aggregates Analyzed by Flow Cytometry as a Promising Tool to Monitor Platelet Activation.
Journal: Journal of clinical medicine
Published: June 25, 2020
Comparative Analysis of a French Prospective Series of 144 Patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the Literature.
Journal: Thrombosis and haemostasis
Published: June 24, 2020
Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants.
Journal: Thrombosis research
Published: July 29, 2019
Rivaroxaban and Apixaban Anti-Xa Measurements: Impact of Plasma Storage for 7 Days at Room Temperature.
Journal: Thrombosis and haemostasis
Published: July 01, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026